By selecting the Yes option, leaving Amgen.nl option you understand that you are leaving the corporate page of Amgen nl and that you will be redirected to another Internet site belonging to third parties, for whose content or opinions Amgen nl is not responsible and makes no representations regarding such content or its accuracy. By selecting this option and accessing linked third party sites, you understand that you do so at your own risk.
The website to which you will be redirected may be designed exclusively for residents of a particular country or countries, as advertised on that website. As a consequence, the website to which you will be directed may contain information on pharmaceutical products or indications that are not approved in nl. If You reside in a country other than the one to which such website is directed, please contact your local Amgen affiliate for the correct information on products in your country of residence.
To enable the best treatment outcome for patients, biologics are indispensable. Biologic medicines are large, complex molecules often 200 to 1,000 times the size of small molecule drugs, such as aspirin, which are chemical compounds delivered in the form of a pill, tablet, or capsule. Biotechnology medicines are too large and intricate to be made using chemistry alone. They are made in living organisms and are highly sensitive, making them significantly more difficult to manufacture.
Amgen is an expert in biologics manufacturing. We have been at the forefront of the medical biotechnology revolution that started in the 1980s, helping invent the processes, methods and technologies that built the global biotechnology industry.
Fulfilling our mission to serve patients means ensuring that all Amgen medicines meet high-quality standards and are supplied reliably to patients around the world.
Amgen has an outstanding track record of reliably delivering medicines to patients who need them. Our highly skilled workforce, disciplined approach to operational excellence and risk mitigation efforts contribute to our commitment to ensure supply for “every patient, every time.”
Our global manufacturing network and significant long-term capital investments allow us to be confident in the face of an emergency or natural disaster and assure we consistently deliver reliability and value to our customers.
Our commitment is to every patient, every time.
Would you like to see how our medicines are packaged in Breda and shipped all over the world? Learn more about what it involves.
FAST FACTS
We have been at the forefront of the medical biotechnology revolution that started in the 1980s, helping invent the processes, methods and technologies that built the global biotechnology industry.